Stanley Hong | SVP, R&D
Celltrion, Inc

Dr. Stanley Hong is currently a Senior Vice President of Celltrion, Inc. in charge of R&D including biosimilar development. He has many experience in development of biopharmaceutical area as well as industrial enzymes. Dr. Hong joined Celltrion from the begining(2002) and made lots of contribution to the establishment of Celltrion which is already public company and located at Incheon, South Korea. Prior to joining Celltrion, he has been working for Samyang Genex Corp about 20 years. At that time Dr. Hong was also in charge of R&D as well, and had a wide range of technical experience from cell culture to microbial fermentation. He has developed many products, and one of them was Taxol using plant cell culture which was successfully commercialized. He was very active scientists as well as business person in this biotech area over past 30 years. Dr. Hong received a Ph.D from Seoul National University in Korea as Enzymology and Biochemical Engineering major, and spent two years at University of Wisconsin for Postdoctoral Fellow.